CUSIP 29842P105COMEPRXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
35 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Vivo Capital, LLC | 1.35M | $10.19M | 0 | Held |
| 2 | Balyasny Asset Management L.P. | 1.35M | $10.19M | 0 | Held |
| 3 | Scotia Capital Inc. | 1.29M | $9.60M | +8.3K | Added |
| 4 | Great Point Partners LLC | 1.20M | $9.06M |
| 0 |
| Held |
| 5 | Point72 Asset Management, L.P. | 712.1K | $5.38M | +712.1K | New |
| 6 | Ikarian Capital, LLC | 610.0K | $4.61M | +610.0K | New |
| 7 | Squadron Capital Management LLC | 500.0K | $3.77M | +500.0K | New Position |
| 8 | Ally Bridge Group (Ny) LLC | 397.9K | $3.00M | −517.1K | Reduced |
| 9 | Velan Capital Investment Management LP | 352.0K | $2.66M | 0 | Held |
| 10 | Affinity Asset Advisors, LLC | 300.0K | $2.27M | 0 | Held |
See every fund holding Eupraxia Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders